Urodynamics and Clinical Factors That Are Associated With Bladder Over-sensitivity
NCT03486639 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 330
Last updated 2020-04-21
Summary
Urodynamic examination evaluates storage and empting phases of the urinary bladder. It enables the clinician to correlate physiologic findings to patients' complains. The data gathered during the examination divided to storage and empting.
During the storage phase, bladder sensation is measured while the bladder is filled with sterile water. During years of practice, we noticed that early sensation (bladder over-sensitivity) is occasionally associated with bladder outlet obstruction (as demonstrated in the emptying phase of the examination.
Conditions
- Overactive Bladder Syndrome
- Bladder Outlet Obstruction
- Benign Prostate Enlargement
- Stress Incontinence (Female) (Male)
- Bladder Disease
Interventions
- OTHER
-
IPSS questionnaire
IPSS is an 8 question (7 symptom questions + 1 quality of life question) written screening tool used to screen for, rapidly diagnose, track the symptoms of, and suggest management of patients with lower urinary tract symptoms. It was validated for both genders.
Sponsors & Collaborators
-
Assaf-Harofeh Medical Center
lead OTHER_GOV
Principal Investigators
-
Kobi Stav, MD · Assaf-Harofeh Medical Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-07-01
- Primary Completion
- 2020-04-01
- Completion
- 2020-08-19
Countries
- Israel
Study Locations
More Related Trials
-
Validation of a Real-time Urodynamic Measure of Urinary Urgency
NCT00909428 ·Status: COMPLETED ·Phase: PHASE4
-
Experience Sampling Method in OAB Patients
NCT03435991 ·Status: UNKNOWN
-
Pilot Trial in Sleep Laboratory Setting to Compare the Physiology of Night Time Bladder Function in Subjects With Overactive Bladder (OAB) Versus Subjects That Have Insomnia and Healthy Normal Subjects
NCT01029015 ·Status: COMPLETED
-
Effects of Antimuscarinic Drugs on Overactive Bladder (OAB) Symptoms After Insertion of Ureteral Stents
NCT01210859 ·Status: WITHDRAWN
-
Urinary Neurotrophin Levels as Potential Biomarkers for Overactive Bladder: A Case-Control Study
NCT06563193 ·Status: ENROLLING_BY_INVITATION
-
Assessing the OAB-8 Questionnaire as a Tool to Measure Treatment Outcome
NCT00313924 ·Status: UNKNOWN ·Phase: PHASE4
-
Examining the Effects of Intra-detrusor Botox at Time of HoLEP in Men With Overactive Bladder Symptoms
NCT05878951 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Evaluating a Digital Intervention for Overactive Bladder
NCT05170100 ·Status: COMPLETED ·Phase: NA
-
Studies of Psychiatric Predisposing Factors, Treatment-related Cardiovascular Effects, and Prognostic Factors Associated With Antimuscarinic Drug (Tolterodine) for Female Overactive Bladder Syndrome
NCT01503580 ·Status: COMPLETED ·Phase: NA
-
Effectiveness and Safety of Duloxetine in Women Experiencing Urinary Leakage Due to Physical Stress and Urge.
NCT00190814 ·Status: COMPLETED ·Phase: PHASE3
-
"Swallow my Urine Back" : Inhibition of Detrusor Overactivity by Swallowing Maneuver
NCT01408771 ·Status: COMPLETED
-
Medication Effects on Periurethral Sensation,Urethral Sphincter Activity and Pressure Flow Parameters
NCT01028014 ·Status: COMPLETED ·Phase: NA
-
Inflammation in Women With Urgency Urinary Incontinence Treated With Anticholinergics
NCT04090190 ·Status: COMPLETED ·Phase: PHASE4
-
To Determine How Effective Duloxetine is in Treating Women 65 Years and Older With Symptoms of Stress Urinary Incontinence, or With a Combination of Stress Urinary Incontinence and Urge Urinary Incontinence Symptoms
NCT00244296 ·Status: COMPLETED ·Phase: PHASE4
-
Developing a Simple Test to Diagnose Overactive Bladder
NCT05572918 ·Status: UNKNOWN
-
Prevalence and Risk Factors Nocturnal Polyuria in Female OAB
NCT03810027 ·Status: COMPLETED
-
A Study of Fesoterodine and Oxybutynin on Cognitive Function in Mild Cognitive Impairment
NCT02240459 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy of Tolterodine on Specific Symptoms in Adult Patients With Overactive Bladder.
NCT00645281 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Tolerability of Propiverine Hydrochloride in Patients With Neurogenic Detrusor Overactivity
NCT01530620 ·Status: COMPLETED ·Phase: PHASE3
-
Urge Incontinence Bladder Overactivity Study
NCT00475696 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Caffeine Reduction and Anticholinergic Medications for Treatment of Overactive Bladder
NCT00780832 ·Status: TERMINATED ·Phase: NA
-
Evaluation of Autonomic System Before and After Anticholinergic Treatment in Women With Overactive Bladder
NCT01409512 ·Status: UNKNOWN
-
Biomechanical Effects of Duloxetine on Bladder and Sphincter Muscle Function in Women in Pure Genuine Stress Incontinence
NCT00190567 ·Status: COMPLETED ·Phase: PHASE2
-
Uroflowmetry and Nocturnal Enuresis
NCT07028645 ·Status: ACTIVE_NOT_RECRUITING
-
Desmopressin Melt Therapy in Patients With Nocturnal Polyuria: a Pharmacokinetic/Dynamic Study
NCT01435083 ·Status: COMPLETED ·Phase: PHASE4